| Dr William Joel Karls, MD | |
|
281 Sawyer Dr, Suite 100, Durango, CO 81303-3409 | |
| (970) 259-2162 | |
| (970) 247-0455 |
| Full Name | Dr William Joel Karls |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 41 Years |
| Location | 281 Sawyer Dr, Durango, Colorado |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770524183 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 34130 (Colorado) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Montrose Memorial Hospital | Montrose, CO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southwest Colorado Mental Health Center Inc | 9133011802 | 44 |
News Archive
For two decades beginning in the late 1970's through 2001, clinicians relied upon laser photocoagulation in the treatment of wet AMD caused by choroidal neovascularization. Attempts to obliterate the neovascular lesions often led to acute central visual loss and often, even with modest success, the lesions recurred with even more vision loss.
The type and quantity of an infant's language exposure relates to their brain function, according to new research published in JNeurosci.
Drug costs could prevent some people from filling their prescriptions, which can interfere with optimal health care. A new study of Medicare beneficiaries finds that cost concerns are more likely keep Hispanics away from the pharmacy counter than non-Hispanics.
Bringing together international experts with the latest technologies and pioneering research, Montefiore Einstein Center for Cancer Care, in collaboration with the National Cancer Institute-designated Albert Einstein Cancer Center, advances the front lines of prevention, diagnosis and treatment of rare and common cancers.
Teva Pharmaceutical Industries Ltd. and Cephalon, Inc. today announced that their Boards of Directors have unanimously approved a definitive agreement under which Teva will acquire all of the outstanding shares of Cephalon for $81.50 per share in cash, or a total enterprise value of approximately $6.8 billion. The transaction is not conditioned on financing and is expected to be completed in the third quarter of 2011.
› Verified 6 days ago
| Entity Name | Southwest Colorado Mental Health Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932192598 PECOS PAC ID: 9133011802 Enrollment ID: O20040326001177 |
News Archive
For two decades beginning in the late 1970's through 2001, clinicians relied upon laser photocoagulation in the treatment of wet AMD caused by choroidal neovascularization. Attempts to obliterate the neovascular lesions often led to acute central visual loss and often, even with modest success, the lesions recurred with even more vision loss.
The type and quantity of an infant's language exposure relates to their brain function, according to new research published in JNeurosci.
Drug costs could prevent some people from filling their prescriptions, which can interfere with optimal health care. A new study of Medicare beneficiaries finds that cost concerns are more likely keep Hispanics away from the pharmacy counter than non-Hispanics.
Bringing together international experts with the latest technologies and pioneering research, Montefiore Einstein Center for Cancer Care, in collaboration with the National Cancer Institute-designated Albert Einstein Cancer Center, advances the front lines of prevention, diagnosis and treatment of rare and common cancers.
Teva Pharmaceutical Industries Ltd. and Cephalon, Inc. today announced that their Boards of Directors have unanimously approved a definitive agreement under which Teva will acquire all of the outstanding shares of Cephalon for $81.50 per share in cash, or a total enterprise value of approximately $6.8 billion. The transaction is not conditioned on financing and is expected to be completed in the third quarter of 2011.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr William Joel Karls, MD Po Box 1328, Durango, CO 81302-1328 Ph: (970) 259-2162 | Dr William Joel Karls, MD 281 Sawyer Dr, Suite 100, Durango, CO 81303-3409 Ph: (970) 259-2162 |
News Archive
For two decades beginning in the late 1970's through 2001, clinicians relied upon laser photocoagulation in the treatment of wet AMD caused by choroidal neovascularization. Attempts to obliterate the neovascular lesions often led to acute central visual loss and often, even with modest success, the lesions recurred with even more vision loss.
The type and quantity of an infant's language exposure relates to their brain function, according to new research published in JNeurosci.
Drug costs could prevent some people from filling their prescriptions, which can interfere with optimal health care. A new study of Medicare beneficiaries finds that cost concerns are more likely keep Hispanics away from the pharmacy counter than non-Hispanics.
Bringing together international experts with the latest technologies and pioneering research, Montefiore Einstein Center for Cancer Care, in collaboration with the National Cancer Institute-designated Albert Einstein Cancer Center, advances the front lines of prevention, diagnosis and treatment of rare and common cancers.
Teva Pharmaceutical Industries Ltd. and Cephalon, Inc. today announced that their Boards of Directors have unanimously approved a definitive agreement under which Teva will acquire all of the outstanding shares of Cephalon for $81.50 per share in cash, or a total enterprise value of approximately $6.8 billion. The transaction is not conditioned on financing and is expected to be completed in the third quarter of 2011.
› Verified 6 days ago
Dr. Susan Grayson, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 303 Blue Spruce Trl, Durango, CO 81301 Phone: 970-259-0321 | |
Paula M Trautner, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 150 Rock Point Dr Ste B, Durango, CO 81301 Phone: 970-249-6116 Fax: 970-249-6116 | |
Patti Lynn Snodgrass, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 281 Sawyer Dr, Suite 100, Durango, CO 81303 Phone: 970-259-2162 Fax: 970-247-5255 | |
Dr. Mark A Braunstein, DO Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2855 Main Ave Suite A105, Four Courners Mental Health, Llc, Durango, CO 81301 Phone: 970-382-6690 Fax: 970-382-0207 | |
Mark David Fallon-cyr, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 281 Sawyer Dr, Suite 100, Durango, CO 81303 Phone: 970-259-2162 Fax: 970-247-0455 | |
Steve Kitson, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 281 Sawyer Dr, Durango, CO 81303 Phone: 970-259-2162 | |
David Rushworth, M.D., PH.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 555 Rivergate Ln Ste B1-102, Durango, CO 81301 Phone: 970-844-2865 Fax: 970-837-3111 |